Concepedia

Yue Zhao

YZ

Statistics

Publications

38

Citations

1.5K

H-Index

22

Active since

1999

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Goethe University Frankfurt

Klinikum Klagenfurt

University Hospital Bonn

Yue Zhao is an author at Bristol-Myers Squibb (United States) specializing in pharmacy, biochemistry, and bioanalytical method validation.

ORCID

Publications per year

1999–2025

38

Publications

38

Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics

Huanzi Zhong, Huahui Ren, Yan Lu et al. · EBioMedicine · 2019 · 207 citations · Full text

, , +17

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

Tania M. Welzel, Jörg Petersen, Kerstin Herzer et al. · Gut · 2016 · 197 citations · Full text

, , +16

A Novel and Cost Effective Method of Removing Excess Albumin from Plasma/Serum Samples and Its Impacts on LC-MS/MS Bioanalysis of Therapeutic Proteins

Guowen Liu, Yue Zhao, Aida Angeles et al. · Analytical Chemistry · 2014 · 87 citations

, , +17

Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression

Hong Shen, Tongtong Liu, Bridget L. Morse et al. · Drug Metabolism and Disposition · 2015 · 85 citations

, , +17

Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme

Christophe Hézode, Pascal Lebray, Victor de Lédinghen et al. · Liver International · 2017 · 79 citations · Full text

, , +16

1–5 of 38